Cargando…

Ultra-Hypofractionated Proton Therapy in Localized Prostate Cancer: Passive Scattering versus Intensity-Modulated Proton Therapy

Few studies have directly compared passive scattering (PS) to intensity-modulated proton therapy (IMPT) in the delivery of ultra-hypofractionated proton beams to the localized prostate cancer (PCa). In this preliminary study involving five patients previously treated with CyberKnife, treatment plans...

Descripción completa

Detalles Bibliográficos
Autores principales:	Borowicz, Dorota Maria, Shipulin, Konstantin N., Mytsin, Gennady V., Skrobała, Agnieszka, Milecki, Piotr, Gayevsky, Victor N., Vondráček, Vladimir, Malicki, Julian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8709262/ https://www.ncbi.nlm.nih.gov/pubmed/34945783 http://dx.doi.org/10.3390/jpm11121311

Ejemplares similares

Dosimetric Comparison of Ultra-Hypofractionated and Conventionally Fractionated Radiation Therapy Boosts for Patients with High-Risk Prostate Cancer
por: Piotrowski, Tomasz, et al.
Publicado: (2022)

The Role of Hypofractionation in Proton Therapy
por: Santos, Alexandre, et al.
Publicado: (2022)

Evaluation of the dosimetric effect of scattered protons in clinical practice in passive scattering proton therapy
por: Kim, Chankyu, et al.
Publicado: (2021)

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy
por: Musielak, Marika, et al.
Publicado: (2021)

Does CyberKnife Improve Dose Distribution Versus IMRT and VMAT on a Linear Accelerator in Low-risk Prostate Cancer?
por: Borowicz, Dorota Maria, et al.
Publicado: (2022)

Comparing Ultra-hypofractionated Proton versus Photon Therapy in Extremity Soft Tissue Sarcoma
por: Thomas, Rehema, et al.
Publicado: (2023)

Dosimetric impact of range uncertainty in passive scattering proton therapy
por: Liu, Ruirui, et al.
Publicado: (2021)

Use of diverging apertures to minimize the edge scatter in passive scattering proton therapy
por: Zhao, Tianyu, et al.
Publicado: (2015)

Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression
por: Kil, Whoon Jong, et al.
Publicado: (2013)

Reduction of superficial radiation dose with bolus in passive scattering proton beam therapy
por: Kim, Yeon‐Joo, et al.
Publicado: (2021)

Passively Scattered Proton Therapy for Nonmelanoma Skin Cancer with Clinical Perineural Invasion
por: Bryant, Curtis M., et al.
Publicado: (2021)

Clinical Efficacy of Hypofractionated Proton Beam Therapy for Intrahepatic Cholangiocarcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2022)

Development of a quasi‐humanoid phantom to perform dosimetric and radiobiological measurements for out‐of‐field doses from external beam radiation therapy
por: Kruszyna‐Mochalska, Marta, et al.
Publicado: (2022)

Prognostic factors of radiation dermatitis following passive-scattering proton therapy for breast cancer
por: Liang, Xiaoying, et al.
Publicado: (2018)

Phase II Study of Hypofractionated Proton Beam Therapy for Hepatocellular Carcinoma
por: Kim, Tae Hyun, et al.
Publicado: (2020)

5-Years Analysis of Effectivity and Toxicity of Ultra-Hypofractionated Proton Radiotherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer—A Retrospective Analysis
por: Kubeš, Jiri, et al.
Publicado: (2023)

In Vitro Comparison of Passive and Active Clinical Proton Beams
por: Michaelidesová, Anna, et al.
Publicado: (2020)

Radiotherapy planning in a prostate cancer phantom model with intraprostatic dominant lesions using stereotactic body radiotherapy with volumetric modulated arcs and a simultaneous integrated boost
por: Skrobala, Agnieszka, et al.
Publicado: (2023)

Comparability of three output prediction models for a compact passively double‐scattered proton therapy system
por: Ferguson, Sven, et al.
Publicado: (2017)

Late radiological changes after passive scattering proton beam therapy for Stage I lung cancer
por: Nakamura, Naoki, et al.
Publicado: (2018)

Medical facility for radiation therapy with JINR proton phasotron beams
por: Abazov, V M, et al.
Publicado: (1994)

Long-term results of a phase II study of hypofractionated proton therapy for prostate cancer: moderate versus extreme hypofractionation
por: Ha, Boram, et al.
Publicado: (2019)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Clinical Effectiveness of Hypofractionated Proton Beam Therapy for Liver Metastasis From Breast Cancer
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Physical and biological impacts of collimator‐scattered protons in spot‐scanning proton therapy
por: Ueno, Koki, et al.
Publicado: (2019)

Treatment outcomes of passive scattering proton beam therapy for stage I non-small cell lung cancer
por: Bayasgalan, Unurjargal, et al.
Publicado: (2021)

Standardized treatment planning methodology for passively scattered proton craniospinal irradiation
por: Giebeler, Annelise, et al.
Publicado: (2013)

A simulation study of in-beam visualization system for proton therapy by monitoring scattered protons
por: Sato, Shogo, et al.
Publicado: (2023)

Comorbidity-Adjusted Survival in Early Stage Lung Cancer Patients Treated with Hypofractionated Proton Therapy
por: Do, Sharon Y., et al.
Publicado: (2010)

Normofractionated and moderately hypofractionated proton therapy: comparison of acute toxicity and early quality of life outcomes
por: Pelak, Maciej J., et al.
Publicado: (2022)

Measuring the Proton Radius in High-Energy Muon-Proton Scattering
por: Friedrich, Jan, et al.
Publicado: (2019)

Combination Intensity Modulated Proton Therapy and Passive Scatter Boost for Rapidly Progressing Nasal Cavity Squamous Cell Carcinoma
por: Ng, Sweet Ping, et al.
Publicado: (2017)

Proton-Proton Elastic Scattering at LHC and Proton Structure
por: Islam, M M, et al.
Publicado: (2010)

Vacuum polarization and proton-proton scattering
por: Foldy, Leslie L, et al.
Publicado: (1955)

High-energy proton-proton scattering
por: Diddens, Albert Nomdo, et al.
Publicado: (1962)

Parity violation in proton-proton scattering
por: Barroso, A
Publicado: (1984)

Proton-proton scattering at 383 Mev
por: Holt, J R, et al.
Publicado: (1956)

Treatment of the uterus cervix cancer with the JINR phasotron proton beam
por: Astrakhan, B V, et al.
Publicado: (1995)

Critical appraisal of the potential role of intensity modulated proton therapy in the hypofractionated treatment of advanced hepatocellular carcinoma
por: Cozzi, Luca, et al.
Publicado: (2018)

High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer
por: Ono, Takashi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_11v2ru1mrdv7ks7k4q1bj6pffp